Litmaps vs Rayyan (2026)

Litmaps

by Litmaps

Rayyan

by Rayyan

Pros

• ✓Literature alerts with map updates is genuinely differentiated — weekly configurable alerts that update existing Litmaps as new papers are published provides ongoing field awareness, materially better than tools focused on snapshot visualization
• ✓Accessible $10/month Pro pricing with country-specific discounts — affordable for individual researchers and graduate students globally, particularly valuable for researchers in lower-income regions where research tool budgets are constrained
• ✓Free tier provides genuine evaluation experience — 2 Litmaps and 100 articles per Map let researchers test the platform meaningfully before paying, lower friction than enterprise alternatives

Limitations

• ⚠Citation visualization is one workflow among many — Litmaps focuses on visualization and alerts but lacks the broader literature search, summarization, and AI research synthesis capabilities that horizontal AI research tools (Elicit, SciSpace, Gemini Deep Research) provide for comprehensive research workflows
• ⚠Smaller installed base than Connected Papers — Litmaps has solid niche positioning but lags Connected Papers' broader brand recognition in the citation visualization category, fewer community resources and tutorial materials
• ⚠Free tier limits create scaling friction — 2 Litmaps and 100 articles per Map require upgrade for productive research workflows, meaningful for evaluation but limiting for active researchers building multiple literature maps

Pros

• ✓Academic-friendly pricing with free tier and student tier is genuinely differentiated — Free for early-career researchers and $4.99/seat student tier make systematic review tools accessible to individual researchers and graduate students that find Covidence or DistillerSR enterprise pricing prohibitive
• ✓Industry-leading duplicate detection — Rayyan's duplicate detection is widely regarded as the best in the systematic review category, materially better than alternatives that produce more false negatives in deduplication
• ✓1M+ researcher installed base provides community resources and validation — extensive global adoption produces materially more learning materials, peer references, and methodology examples than smaller systematic review alternatives

Limitations

• ⚠Less depth than enterprise systematic review tools (Covidence, DistillerSR) — Rayyan is solid for academic and SMB systematic review but lacks the workflow customization, advanced reporting, and enterprise-specific features that dedicated commercial alternatives provide for high-stakes regulatory and clinical work
• ⚠Free tier limits create scaling friction — 3 active reviews and 2 reviewers per review on Free tier require upgrade for active research teams, meaningful for cost-conscious individual researchers but limiting for productive research operations
• ⚠Specialized for systematic reviews limits broader research use cases — Rayyan is purpose-built for evidence synthesis and lacks the broader literature search, citation analysis, and AI research capabilities that horizontal AI research tools (Elicit, Scite.ai, SciSpace) provide